Recordati | REC - Cost Of Sales

Stock Price
44.48
Daily Change
-0.18 -0.40%
Monthly
-7.68%
Yearly
-17.63%
Q1 Forecast
44.07

Recordati reported EUR199.91M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Almirall EUR 191.5M 2.29M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Orion EUR 186.6M 17.6M Dec/2025
Sanofi EUR 4.29B 421M Dec/2025